JVIR's impact factor increases nearly 15% during 2010

NewsGuard 100/100 Score

The Journal of Vascular and Interventional Radiology's impact factor—the measure of a journal's "impact" (or significance) based on the number of article citations compared to the total number of articles published—increased nearly 15 percent in 2010. While the journal's quality and influence has remained consistently high over the past five years, the journal's core strengths have been enhanced recently by the increased use of new media (such as podcasts), a reconfigured internationally focused editorial board and an average time-to-first decision of under 30 days for new manuscripts.

"The Journal of Vascular and Interventional Radiology's increased ranking reflects the journal's unflagging commitment to quality and tradition of excellence, showing it as an essential resource for interventional radiologists, radiologists, cardiologists, vascular surgeons, neurosurgeons and other clinicians across the United States and the world who need current and reliable information on every aspect of vascular and interventional radiology," said editor in chief Ziv J Haskal, M.D., FSIR. "JVIR is the highest ranked interventional radiology journal in the world. It continues to be the vigorous forum for the most novel and impactful, global, cutting-edge, basic science research, clinical reports and evidence-based medicine. JVIR science can truly provide patients with the best possible health care," he added. "Always innovative, JVIR is providing rapid, tight reviewing and early decision—giving authors visibility for their research and readers increased access to more information through multiple new channels," said Haskal. "These results confirm JVIR's position as a lead destination for research in peripheral vascular and venous disease, oncology, women's health and all other aspects of endovascular therapy," noted the professor of radiology and surgery at the University of Maryland School of Medicine and vice chair of strategic development and chief of vascular and interventional radiology, image-guided therapy and interventional oncology at the University of Maryland Medical Center, both in Baltimore, Md.

JVIR—the monthly, peer-reviewed flagship publication of the Society of Interventional Radiology—earned an impact factor of 2.064, an increase from 1.805 in 2009, according to new data released in the 2010 Journal Citation Reports® published by Thomson Reuters. JVIR ranks higher than other prominent journals in the radiology, nuclear medicine and medical imaging category, such as CardioVascular and Interventional Radiology (CVIR). The impact factor is often used as a measure of the quality and influence of medical journals within scientific, professional and academic communities. JVIR published 275 articles in 2010, earning 5,900 citations among radiology, nuclear medicine and medical imaging journals and peripheral vascular disease journals.

The journal's continued excellence is the result of the efforts of the current editorial board—renowned reviewers from around the globe who ensure uniformity, fairness and efficiency in manuscript handling, comments and revisions—as well as Albert A. Nemcek Jr., M.D., FSIR, the journal's previous editor, and previous editorial board members, said Haskal. "JVIR's efforts continue to highlight the global impact of this minimally invasive specialty and its lead journal," he added.

The journal has further expanded the ways in which it delivers news of the specialty with the new JVIR podcast channel, providing short, hard-hitting interviews that provide insight into methodology, controversy and next directions for research, said Haskal. JVIR's Web site has been redesigned and includes many new features, such as improved navigation; access to current articles, features and issues; and the most up-to-date information on research and other interventional radiology news. JVIR podcasts are also available on SIR's Web site (www.SIRweb.org).

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unraveling the complexities of muscle repair in diabetes: A call for targeted research and therapies